Andrea Difabio

Companies

• Xenon PharmaceuticalsGeneral counsel Nov 9, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Xenon Pharmaceuticals XENE7,301 shares²$255.8K at $35.03Mar 13, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 13, 2026Sold 1,342 shares at $55.23 of Xenon Pharmaceuticals²
• Mar 12, 2026Exercised options 3,750 shares of Xenon Pharmaceuticals²
• Mar 10, 2026Sold 2,607 shares at $60.11 of Xenon Pharmaceuticals³
• Mar 9, 2026Exercised options 7,500 shares of Xenon Pharmaceuticals³